The Potential Biomark of Serious Psychosis:a Prospective,Case-controled Study

NCT02202460 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2014-07-29

No results posted yet for this study

Summary

Patients suffer from Serious Psychosis may have variation in immunological factors,BDNF and MRI.

Conditions

  • Other Immunological States or Disorders

Sponsors & Collaborators

  • Central South University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2016-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02202460 on ClinicalTrials.gov